<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35366162</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7217</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>193</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Breast cancer research and treatment</Title>
          <ISOAbbreviation>Breast Cancer Res Treat</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer.</ArticleTitle>
        <Pagination>
          <StartPage>495</StartPage>
          <EndPage>505</EndPage>
          <MedlinePgn>495-505</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-022-06571-x</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This case-control study assesses the independent roles of reproductive history, postmenopausal hormonal therapy (HT), socioeconomic status (SES), and occupational physical activity on the risk of breast cancer (BC).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Odds ratios (OR) were estimated from conditional logistic multivariate regression model in a data set of 19,253 Finnish women diagnosed with BC between 1994 and 2013 and 96,265 age-matched population controls.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Both pre- and postmenopausal white-collar workers had significantly increased risk of ductal and lobular BC as compared to manual workers. Moderate occupational physical activity reduced risk of lobular BC by 14%. There was a transient increase in the risk of BC observed after each birth followed by a protective effect starting some years after the delivery. As the number of children increased, the short-term excess risk was lower and protective effect was observed earlier. Continuous estrogen-progestin therapy (EPT) significantly increased the risk of both ductal and lobular BC and the magnitude of risk was directly proportional to duration of use (OR for 5+ years of use 2.26, 95% confidence interval 2.12-2.42). Monthly EPT for 5+ years increased the risk (OR 1.32, 95% CI 1.20-1.45). Users of estradiol plus levonorgestrel intrauterine system devices showed ORs of 1.56 (95% CI 1.45-1.69) and 2.18 (95% CI 1.81-2.64) for ductal and lobular BC, respectively.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study concludes that pregnancy has a dual effect on BC risk, with a transient increase in risk followed by a long-term protective effect. The SES and HT have a large effect on BC risk while occupational physical activity has only a small independent effect.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Katuwal</LastName>
            <ForeName>Sushmita</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-3017-9430</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland. sushmita.katuwal@tuni.fi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tapanainen</LastName>
            <ForeName>Juha</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pukkala</LastName>
            <ForeName>Eero</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Breast Cancer Res Treat</MedlineTA>
        <NlmUniqueID>8111104</NlmUniqueID>
        <ISSNLinking>0167-6806</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018275" MajorTopicYN="Y">Carcinoma, Lobular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017584" MajorTopicYN="N">Reproductive History</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012923" MajorTopicYN="N">Social Class</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Breast cancer</Keyword>
        <Keyword MajorTopicYN="N">Etiology</Keyword>
        <Keyword MajorTopicYN="N">Hormonal replacement therapy</Keyword>
        <Keyword MajorTopicYN="N">Parity</Keyword>
        <Keyword MajorTopicYN="N">Physical activity</Keyword>
        <Keyword MajorTopicYN="N">Risk factors</Keyword>
        <Keyword MajorTopicYN="N">Socio-economic status</Keyword>
      </KeywordList>
      <CoiStatement>All authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>12</Hour>
          <Minute>5</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35366162</ArticleId>
        <ArticleId IdType="pmc">PMC9090885</ArticleId>
        <ArticleId IdType="doi">10.1007/s10549-022-06571-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s10549-022-06571-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al.  Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71(3):209–249.</Citation>
        </Reference>
        <Reference>
          <Citation>Pitkäniemi J, Malila N, Virtanen A, Degerlund H, Heikkinen S, Seppä K (2020) Cancer in Finland 2018. Cancer Society of Finland Publication No. 94, Helsinki</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang J, Wang M, Wang X, Li Y, Liang Z, Lin Y, et al.  Associations of reproductive factors with breast cancer prognosis and the modifying effects of menopausal status. Cancer Med. 2020;9(1):385–393. doi: 10.1002/cam4.2707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cam4.2707</ArticleId>
            <ArticleId IdType="pmc">PMC6943140</ArticleId>
            <ArticleId IdType="pubmed">31724329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005;92(1):167–175. doi: 10.1038/sj.bjc.6602302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6602302</ArticleId>
            <ArticleId IdType="pmc">PMC2361726</ArticleId>
            <ArticleId IdType="pubmed">15597097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen AH. Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the nurses' health studies. Int J Cancer. 2016;138(10):2346–2356. doi: 10.1002/ijc.29968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.29968</ArticleId>
            <ArticleId IdType="pmc">PMC5245093</ArticleId>
            <ArticleId IdType="pubmed">26684063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Troisi R, Bjørge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Saether SM, et al.  The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med. 2018;283(5):430–445. doi: 10.1111/joim.12747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/joim.12747</ArticleId>
            <ArticleId IdType="pmc">PMC6688839</ArticleId>
            <ArticleId IdType="pubmed">29476569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez SV, Russo J. Estrogen and xenoestrogens in breast cancer. Toxicol Pathol. 2010;38(1):110–122. doi: 10.1177/0192623309354108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0192623309354108</ArticleId>
            <ArticleId IdType="pmc">PMC2907875</ArticleId>
            <ArticleId IdType="pubmed">19933552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 2006;102(1):89–96. doi: 10.1016/j.jsbmb.2006.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsbmb.2006.09.004</ArticleId>
            <ArticleId IdType="pmc">PMC1832080</ArticleId>
            <ArticleId IdType="pubmed">17113977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35. doi: 10.1093/oxfordjournals.epirev.a036102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.epirev.a036102</ArticleId>
            <ArticleId IdType="pubmed">8405201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dickson RB, Lippman ME. Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res. 1988;40:119–165. doi: 10.1007/978-1-4613-1733-3_6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4613-1733-3_6</ArticleId>
            <ArticleId IdType="pubmed">2908648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brusselaers N, Tamimi RM, Konings P, Rosner B, Adami HO, Lagergren J. Different menopausal hormone regimens and risk of breast cancer. Ann Oncol. 2018;29(8):1771–1776. doi: 10.1093/annonc/mdy212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/annonc/mdy212</ArticleId>
            <ArticleId IdType="pubmed">29917061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyytinen K, Dyba T, Ylikorkala O, Pukkala E. A case-control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well. Int J Cancer. 2010;126(2):483–489. doi: 10.1002/ijc.24738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.24738</ArticleId>
            <ArticleId IdType="pubmed">19588504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet 394(10204):1159–1168 (2019)</Citation>
        </Reference>
        <Reference>
          <Citation>Moradi T, Adami H, Bergström R, Gridley G, Wolk A, Gerhardsson M, et al.  Occupational physical activity and risk for breast cancer in a nationwide cohort study in Sweden. Cancer Causes Control. 1999;10(5):423–430. doi: 10.1023/A:1008922205665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1008922205665</ArticleId>
            <ArticleId IdType="pubmed">10530613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekenga CC, Parks CG, Sandler DP. A prospective study of occupational physical activity and breast cancer risk. Cancer Causes Control. 2015;26(12):1779–1789. doi: 10.1007/s10552-015-0671-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10552-015-0671-8</ArticleId>
            <ArticleId IdType="pmc">PMC4664182</ArticleId>
            <ArticleId IdType="pubmed">26450605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Wang Q, Zhang Y, Xie Q, Tan X. Physical Activity and Risk of Breast Cancer: a meta-analysis of 38 cohort studies in 45 study reports. Value in Health. 2019;22(1):104–128. doi: 10.1016/j.jval.2018.06.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jval.2018.06.020</ArticleId>
            <ArticleId IdType="pubmed">30661625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luoto R, Latikka P, Pukkala E, Hakulinen T, Vihko V. The effect of physical activity on breast cancer risk: a cohort study of 30,548 women. Eur J Epidemiol. 2000;16(10):973–980. doi: 10.1023/A:1010847311422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1010847311422</ArticleId>
            <ArticleId IdType="pubmed">11338130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo W, Fensom GK, Reeves GK, Key TJ. Physical activity and breast cancer risk: results from the UK Biobank prospective cohort. Br J Cancer. 2020;122(5):726–732. doi: 10.1038/s41416-019-0700-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41416-019-0700-6</ArticleId>
            <ArticleId IdType="pmc">PMC7054300</ArticleId>
            <ArticleId IdType="pubmed">31919405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyle G, Hendrie GA, Hendrie D. Understanding the effects of socioeconomic status along the breast cancer continuum in Australian women: a systematic review of evidence. Int J Equity Health. 2017;16(1):182. doi: 10.1186/s12939-017-0676-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12939-017-0676-x</ArticleId>
            <ArticleId IdType="pmc">PMC5644132</ArticleId>
            <ArticleId IdType="pubmed">29037209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundqvist A, Andersson E, Ahlberg I, Nilbert M, Gerdtham U. Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis. Eur J Public Health. 2016;26(5):804–813. doi: 10.1093/eurpub/ckw070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurpub/ckw070</ArticleId>
            <ArticleId IdType="pmc">PMC5054273</ArticleId>
            <ArticleId IdType="pubmed">27221607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen SB, Olsen A, Lynch J, Christensen J, Overvad K, Tjønneland A, et al.  Socioeconomic position and lifestyle in relation to breast cancer incidence among postmenopausal women: a prospective cohort study, Denmark, 1993–2006. Cancer Epidemiol. 2011;35(5):438–441. doi: 10.1016/j.canep.2010.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canep.2010.12.005</ArticleId>
            <ArticleId IdType="pubmed">21227766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pukkala E, Weiderpass E. Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971–1995) Int J Cancer. 1999;81(1):56–61. doi: 10.1002/(SICI)1097-0215(19990331)81:1&lt;56::AID-IJC11&gt;3.0.CO;2-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-0215(19990331)81:1&lt;56::AID-IJC11&gt;3.0.CO;2-4</ArticleId>
            <ArticleId IdType="pubmed">10077153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katuwal S, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, et al.  Occupational variation in the risk of female breast cancer in the Nordic countries. Cancer Causes Control. 2018;29(11):1027–1038. doi: 10.1007/s10552-018-1076-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10552-018-1076-2</ArticleId>
            <ArticleId IdType="pubmed">30151565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature. 1983;303(5920):767–770. doi: 10.1038/303767a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/303767a0</ArticleId>
            <ArticleId IdType="pubmed">6866078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pukkala E, Engholm G, HøjsgaardSchmidt LK, Storm H, Khan S, Lambe M, et al.  Nordic Cancer Registries—an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–455. doi: 10.1080/0284186X.2017.1407039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/0284186X.2017.1407039</ArticleId>
            <ArticleId IdType="pubmed">29226751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Statistics Finland. Classification of Socio-economic Groups. https://www.stat.fi/en/luokitukset/sosioekon_asema/. Accessed 16 Dec 2020</Citation>
        </Reference>
        <Reference>
          <Citation>Kauppinen T, Heikkilä P, Plato N, Woldbaek T, Lenvik K, Hansen J, et al.  Construction of job-exposure matrices for the Nordic Occupational Cancer Study (NOCCA) Acta Oncol. 2009;48(5):791–800. doi: 10.1080/02841860902718747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02841860902718747</ArticleId>
            <ArticleId IdType="pubmed">19225948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Backman T, Huhtala S, Tuominen J, Luoto R, Erkkola R, Blom T, et al.  Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland. Eur J Contracept Reprod Health Care. 2001;6(suppl 1):23–26. doi: 10.3109/ejc.6.s1.23.26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/ejc.6.s1.23.26</ArticleId>
            <ArticleId IdType="pubmed">11336430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danø H, Hansen KD, Jensen P, Petersen JH, Jacobsen R, Ewertz M, et al.  Fertility pattern does not explain social gradient in breast cancer in Denmark. Int J Cancer. 2004;111(3):451–456. doi: 10.1002/ijc.20203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.20203</ArticleId>
            <ArticleId IdType="pubmed">15221976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hemminki K, Zhang H, Czene K. Socioeconomic factors in cancer in Sweden. Int J Cancer. 2003;105(5):692–700. doi: 10.1002/ijc.11150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.11150</ArticleId>
            <ArticleId IdType="pubmed">12740920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rimpelä AH, Pukkala EI. Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms. Soc Sci Med. 1987;24(7):601–606. doi: 10.1016/0277-9536(87)90064-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0277-9536(87)90064-5</ArticleId>
            <ArticleId IdType="pubmed">3589754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rimpelä A, Rimpelä M (1983) Biological growth and maturation, in health habits among Finnish youth. Health Education. Series Original Reports 4/1984</Citation>
        </Reference>
        <Reference>
          <Citation>Helakorpi S, Patja K, Prättälä R, Uutela A.  Health behaviour and health among the Finnish adult population, publications of the National Public Health Institute 18/2005. Helsinki (in Finnish with English abstract): National Public Health Institute; 2005. </Citation>
        </Reference>
        <Reference>
          <Citation>Johnsson A, Broberg P, Johnsson A, Tornberg ÅB, Olsson H. Occupational sedentariness and breast cancer risk. Acta Oncol. 2017;56(1):75–80. doi: 10.1080/0284186X.2016.1262547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/0284186X.2016.1262547</ArticleId>
            <ArticleId IdType="pubmed">27919198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Zhao H, Peng C. Association of sedentary behavior with the risk of breast cancer in women: update meta-analysis of observational studies. Ann Epidemiol. 2015;25(9):687–697. doi: 10.1016/j.annepidem.2015.05.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annepidem.2015.05.007</ArticleId>
            <ArticleId IdType="pubmed">26099193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedenreich CM, Cust AE. Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med. 2008;42(8):636–647. doi: 10.1136/bjsm.2006.029132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjsm.2006.029132</ArticleId>
            <ArticleId IdType="pubmed">18487249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, et al.  Physical activity and breast cancer: a systematic review. Epidemiology. 2007;18(1):137–157. doi: 10.1097/01.ede.0000251167.75581.98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.ede.0000251167.75581.98</ArticleId>
            <ArticleId IdType="pubmed">17130685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rintala P, Pukkala E, Läärä E, Vihko V. Physical activity and breast cancer risk among female physical education and language teachers: a 34-year follow-up. Int J Cancer. 2003;107(2):268–270. doi: 10.1002/ijc.11390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.11390</ArticleId>
            <ArticleId IdType="pubmed">12949805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lynch BM, Courneya KS, Friedenreich CM. A case-control study of lifetime occupational sitting and likelihood of breast cancer. Cancer Causes Control. 2013;24(6):1257–1262. doi: 10.1007/s10552-013-0194-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10552-013-0194-0</ArticleId>
            <ArticleId IdType="pubmed">23526070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colditz GA, Feskanich D, Chen WY, Hunter DJ, Willett WC. Physical activity and risk of breast cancer in premenopausal women. Br J Cancer. 2003;89(5):847–851. doi: 10.1038/sj.bjc.6601175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6601175</ArticleId>
            <ArticleId IdType="pmc">PMC2394493</ArticleId>
            <ArticleId IdType="pubmed">12942116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee IM, Cook NR, Rexrode KM, Buring JE. Lifetime physical activity and risk of breast cancer. Br J Cancer. 2001;85(7):962–965. doi: 10.1054/bjoc.2001.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1054/bjoc.2001.2003</ArticleId>
            <ArticleId IdType="pmc">PMC2375108</ArticleId>
            <ArticleId IdType="pubmed">11592766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irwin ML. Randomized controlled trials of physical activity and breast cancer prevention. Exerc Sport Sci Rev. 2006;34(4):182–193. doi: 10.1249/01.jes.0000240026.15126.ca.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1249/01.jes.0000240026.15126.ca</ArticleId>
            <ArticleId IdType="pubmed">17031257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention. Recent results Cancer Res. 2011;186:13–42. doi: 10.1007/978-3-642-04231-7_2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-642-04231-7_2</ArticleId>
            <ArticleId IdType="pubmed">21113759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr. 2002;132(11 Suppl):3456S–3464S. doi: 10.1093/jn/132.11.3456S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jn/132.11.3456S</ArticleId>
            <ArticleId IdType="pubmed">12421870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8(4):R43. doi: 10.1186/bcr1525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/bcr1525</ArticleId>
            <ArticleId IdType="pmc">PMC1779465</ArticleId>
            <ArticleId IdType="pubmed">16859501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DSM. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1643–1654. doi: 10.1158/1055-9965.EPI-10-0188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1055-9965.EPI-10-0188</ArticleId>
            <ArticleId IdType="pmc">PMC2882996</ArticleId>
            <ArticleId IdType="pubmed">20501751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, et al.  Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005;93(3):364–371. doi: 10.1038/sj.bjc.6602712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6602712</ArticleId>
            <ArticleId IdType="pmc">PMC2361558</ArticleId>
            <ArticleId IdType="pubmed">16079783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reeves GK, Pirie K, Green J, Bull D, Beral V, Million Women SC. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer. 2009;100(3):538–544. doi: 10.1038/sj.bjc.6604853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6604853</ArticleId>
            <ArticleId IdType="pmc">PMC2658546</ArticleId>
            <ArticleId IdType="pubmed">19190634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, et al.  Late age at first full term birth is strongly associated with lobular breast cancer. Cancer. 2011;117(9):1946–1956. doi: 10.1002/cncr.25728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.25728</ArticleId>
            <ArticleId IdType="pmc">PMC3117094</ArticleId>
            <ArticleId IdType="pubmed">21509772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, et al.  Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol. 2008;167(2):230–239. doi: 10.1093/aje/kwm271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwm271</ArticleId>
            <ArticleId IdType="pmc">PMC3804121</ArticleId>
            <ArticleId IdType="pubmed">17965112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo J, Wilgus G, Russo IH. Susceptibility of the mammary gland to carcinogenesis: I differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol. 1979;96(3):721–736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2042395</ArticleId>
            <ArticleId IdType="pubmed">112872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, et al.  Dual effect of parity on breast cancer risk. Eur J Cancer. 1994;30A(7):969–973. doi: 10.1016/0959-8049(94)90125-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0959-8049(94)90125-2</ArticleId>
            <ArticleId IdType="pubmed">7946593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clavel-Chapelon F, E3N Group  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control. 2002;13(9):831–838. doi: 10.1023/A:1020684821837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1020684821837</ArticleId>
            <ArticleId IdType="pmc">PMC2001234</ArticleId>
            <ArticleId IdType="pubmed">12462548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CI, Daling JR, Haugen KL, Tang MTC, Porter PL, Malone KE. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55–74 years of age. Breast Cancer Res Treat. 2014;145(2):481–489. doi: 10.1007/s10549-014-2960-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10549-014-2960-4</ArticleId>
            <ArticleId IdType="pmc">PMC4075765</ArticleId>
            <ArticleId IdType="pubmed">24748570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO. Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat. 1996;38(3):305–311. doi: 10.1007/BF01806150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01806150</ArticleId>
            <ArticleId IdType="pubmed">8739084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clavel-Chapelon F, Gerber M. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat. 2002;72(2):107–115. doi: 10.1023/A:1014891216621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1014891216621</ArticleId>
            <ArticleId IdType="pmc">PMC1925053</ArticleId>
            <ArticleId IdType="pubmed">12038701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Högnäs E, Kauppila A, Pukkala E, Tapanainen JS. Cancer risk in women with 10 or more delveries. Obstet Gynecol. 2014;123(4):811–816. doi: 10.1097/AOG.0000000000000182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000000182</ArticleId>
            <ArticleId IdType="pubmed">24785609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katuwal S, Tapanainen JS, Pukkala E, Kauppila A. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women. BMC Cancer. 2019;19(1):199. doi: 10.1186/s12885-019-5404-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12885-019-5404-z</ArticleId>
            <ArticleId IdType="pmc">PMC6399864</ArticleId>
            <ArticleId IdType="pubmed">30832620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nyante SJ, Dallal CM, Gierach GL, Park Y, Hollenbeck AR, Brinton LA. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol. 2013;178(3):359–371. doi: 10.1093/aje/kws471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kws471</ArticleId>
            <ArticleId IdType="pmc">PMC3727333</ArticleId>
            <ArticleId IdType="pubmed">23899816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woods KL, Smith SR, Morrison JM. Parity and breast cancer: evidence of a dual effect. Br Med J. 1980;281(6237):419–421. doi: 10.1136/bmj.281.6237.419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.281.6237.419</ArticleId>
            <ArticleId IdType="pmc">PMC1713272</ArticleId>
            <ArticleId IdType="pubmed">7427299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q, Wuu J, Lambe M, Hsieh S, Ekbom A, Hsieh C. Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden) Cancer Causes Control. 2002;13(4):299–305. doi: 10.1023/A:1015287208222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1015287208222</ArticleId>
            <ArticleId IdType="pubmed">12074499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012;62(3):263–271. doi: 10.1016/j.yhbeh.2012.02.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yhbeh.2012.02.023</ArticleId>
            <ArticleId IdType="pmc">PMC3376705</ArticleId>
            <ArticleId IdType="pubmed">22406114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev. 2002;11(4):361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11927496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 2006;102(1–5):89–96. doi: 10.1016/j.jsbmb.2006.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsbmb.2006.09.004</ArticleId>
            <ArticleId IdType="pmc">PMC1832080</ArticleId>
            <ArticleId IdType="pubmed">17113977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collaborative Group on Hormonal Factors in Breast Cancer  Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159–1168. doi: 10.1016/S0140-6736(19)31709-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(19)31709-X</ArticleId>
            <ArticleId IdType="pmc">PMC6891893</ArticleId>
            <ArticleId IdType="pubmed">31474332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol. 2006;108(6):1354–1360. doi: 10.1097/01.AOG.0000241091.86268.6e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.AOG.0000241091.86268.6e</ArticleId>
            <ArticleId IdType="pubmed">17138766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang SM, Manson JE, Rexrode KM, Cook NR, Buring JE, Lee I. Use of oral conjugated estrogen alone and risk of breast cancer. Am J Epidemiol. 2007;165(5):524–529. doi: 10.1093/aje/kwk038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwk038</ArticleId>
            <ArticleId IdType="pubmed">17132697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, et al.  Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(1):144–156. doi: 10.1002/ijc.25314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.25314</ArticleId>
            <ArticleId IdType="pubmed">20232395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haugen KL, et al.  Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA. 2003;289(24):3254–3263. doi: 10.1001/jama.289.24.3254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.289.24.3254</ArticleId>
            <ArticleId IdType="pubmed">12824206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Román M, Sakshaug S, Graff-Iversen S, Vangen S, Weiderpass E, Ursin G, et al.  Postmenopausal hormone therapy and the risk of breast cancer in Norway. Int J Cancer. 2016;138(3):584–593. doi: 10.1002/ijc.29810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.29810</ArticleId>
            <ArticleId IdType="pubmed">26289549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362(9382):419–427 (2003)</Citation>
        </Reference>
        <Reference>
          <Citation>Wood CE, Branstetter D, Jacob AP, Cline JM, Register TC, Rohrbach K, et al.  Progestin effects on cell proliferation pathways in the postmenopausal mammary gland. Breast Cancer Res. 2013;15(4):R62. doi: 10.1186/bcr3456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/bcr3456</ArticleId>
            <ArticleId IdType="pmc">PMC3978455</ArticleId>
            <ArticleId IdType="pubmed">23938070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santen RJ, Pinkerton J, McCartney C, Petroni GR. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy. J Clin Endocrinol Metab. 2001;86(1):16–23. doi: 10.1210/jcem.86.1.7269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.86.1.7269</ArticleId>
            <ArticleId IdType="pubmed">11231971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsson HL, Ingvar C, Bladström A. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Cancer. 2003;97(6):1387–1392. doi: 10.1002/cncr.11205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.11205</ArticleId>
            <ArticleId IdType="pubmed">12627501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, et al.  Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(7):593–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12101105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conz L, Mota BS, Bahamondes L, TeixeiraDória M, Françoise MauricetteDerchain S, Rieira R, et al.  Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2020;99(8):970–982. doi: 10.1111/aogs.13817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/aogs.13817</ArticleId>
            <ArticleId IdType="pubmed">31990981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Joensuu H, et al.  Levonorgestrel-releasing intrauterine system and the risk of breast cancer: a nationwide cohort study. Acta Oncol. 2016;55(2):188–192. doi: 10.3109/0284186X.2015.1062538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/0284186X.2015.1062538</ArticleId>
            <ArticleId IdType="pubmed">26243443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Obstet Gynecol. 2014;124(2 Pt 1):292–299. doi: 10.1097/AOG.0000000000000356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000000356</ArticleId>
            <ArticleId IdType="pubmed">25004338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pukkala E. Biobanks and registers in epidemiologic research on cancer. Methods Mol Biol. 2011;11(675):127–164. doi: 10.1007/978-1-59745-423-0_5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-59745-423-0_5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 1994;33(4):365–369. doi: 10.3109/02841869409098430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/02841869409098430</ArticleId>
            <ArticleId IdType="pubmed">8018367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prättälä R, Sippola R, Lahti-Koski M, Laaksonen MT, Mäkinen T, Roos E. Twenty-five-year trends in body mass index by education and income in Finland. BMC Public Health. 2012;12(1):936. doi: 10.1186/1471-2458-12-936.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2458-12-936</ArticleId>
            <ArticleId IdType="pmc">PMC3526569</ArticleId>
            <ArticleId IdType="pubmed">23113905</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
